Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PADI4 | Q9UM07 | 13/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | KDM5A | P29375 | 5/20 | 0.46 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25432294 | 1.00 | PADI4 (0.56) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL31139843 | 1.00 | PADI4 (0.56) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL30590358 | 1.00 | PADI4 (0.56) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL25431584 | 0.91 | PADI4 (0.56) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL31139794 | 0.91 | PADI4 (0.56) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL25431587 | 0.91 | PADI4 (0.56) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL30590387 | 0.91 | PADI4 (0.56) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL25434661 | 0.83 | PADI4 (0.78) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL25431384 | 0.83 | SMN1; SMN2 (0.61) | PADI4LMNAHTTSMN1; SMN2NPSR1 | |
| SCHEMBL25431389 | 0.83 | SMN1; SMN2 (0.61) | PADI4LMNAHTTSMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023161782-A1 | NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS | SATYARX PHARMA INNOVATIONS PVT LTD (IN) | 2023-08-31 | — | — | WO | disclosed |